Skip to main content
SpringerLink
Log in

The remarkable effect of ivabradine in two adolescents with dilated cardiomyopathy

  • Letter to the Editors
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Arola A et al (1998) Idiopathic dilated cardiomyopathy in children: prognostic indicators and outcome. Pediatrics 101(3 Pt 1):76–369

    Google Scholar 

  2. Taliercio CP et al (1985) Idiopathic dilated cardiomyopathy in the young: clinical profile and natural history. J Am Coll Cardiol 6(5):31–1126

    Article  Google Scholar 

  3. Harmon WE et al (2005) Pediatric transplantation, 1994–2003. Am J Transplant 5(4 Pt 2):887–903

    Article  PubMed  Google Scholar 

  4. Shaddy RE et al (2007) Carvedilol for children and adolescents with heart failure––a randomized controlled trial. JAMA 298(10):1171–1179

    Article  PubMed  Google Scholar 

  5. Lewis AB (1999) Late recovery of ventricular function in children with idiopathic dilated cardiomyopathy. Am Heart J 138(2 Pt 1):8–334

    Google Scholar 

  6. Sliwa K et al (2010) Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 12(8):78–767

    Article  Google Scholar 

  7. Brookes CI et al (1995) Angiography and the aetiology of heart failure. Postgrad Med J 71(838):2–480

    Article  Google Scholar 

  8. Cleland JG et al (2003) Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial. Lancet 362(9377):14–21

    Article  CAS  PubMed  Google Scholar 

  9. Ghio S et al (2009) Long-term left ventricular reverse remodelling with cardiac resynchronization therapy: results from the CARE-HF trial. Eur J Heart Fail 11(5):8–480

    Article  Google Scholar 

  10. Bonnet D et al. Determination of the efficacious and safe dose of ivabradine in paediatric patients with dilated cardiomyopathy and symptomatic chronic heart failure from ages 6 months to 18 years. ISRCTN 1186/ISRCTN60567801. Ongoing

Download references

Author information

Authors and Affiliations

  1. Department of Academic Cardiology, Hull and East Yorkshire Medical Research and Teaching Centre, MRTDS (Daisy) Building, Castle Hill Hospital, Cottingham, Kingston upon Hull, HU16 5JQ, UK

    Sunaina Parsons, Andrew L. Clark & John G. F. Cleland

Authors
  1. Sunaina Parsons
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrew L. Clark
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. John G. F. Cleland
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sunaina Parsons.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Parsons, S., Clark, A.L. & Cleland, J.G.F. The remarkable effect of ivabradine in two adolescents with dilated cardiomyopathy. Clin Res Cardiol 103, 847–849 (2014). https://doi.org/10.1007/s00392-014-0731-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-014-0731-1

Keywords

Search

Navigation